Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
History of or current diagnosis with kidney and/or liver diseases
Chronic constipation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to day 28 and 56
Awards & highlights
Summary
This trial aims to see if probiotics can help improve gut function in people with occasional constipation by reducing the transit time. Participants will be randomly assigned to take either probiotics or a placebo.
Who is the study for?
This trial is for individuals who experience occasional constipation and want to explore if probiotics can help improve their gut function. Specific eligibility criteria are not provided, but typically participants must be in good general health with no conflicting medical conditions.
What is being tested?
The study is testing the effectiveness of probiotics versus a placebo (a harmless inactive substance) on improving gastrointestinal function in people with occasional constipation. Participants will be randomly assigned to one of the two groups.
What are the potential side effects?
While specific side effects are not listed, generally probiotics may cause mild digestive symptoms such as gas or bloating, especially when first starting them. Placebos typically have no side effects since they contain no active ingredients.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have or had kidney or liver disease.
Select...
I have chronic constipation.
Select...
I have or had a thyroid condition.
Select...
I do not have any unstable chronic conditions.
Select...
I have diabetes (Type I or II) and cancer.
Select...
I have had a major heart problem in the last 6 months.
Select...
I have no significant history of serious gastrointestinal diseases.
Select...
My blood pressure is not well-controlled.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to day 28 and 56
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to day 28 and 56
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Transit time
Secondary outcome measures
Bloating and flatulence
Bowel movements
Digestive symptoms
+2 moreTrial Design
2Treatment groups
Active Control
Placebo Group
Group I: ProbioticsActive Control1 Intervention
Group II: PlaceboPlacebo Group1 Intervention
Find a Location
Who is running the clinical trial?
Probi ABLead Sponsor
22 Previous Clinical Trials
4,065 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger